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Abstract Metabolism is a highly integrated process resulting in energy and biomass production.
While individual metabolic routes are well characterized, the mechanisms ensuring crosstalk
between pathways are poorly described, although they are crucial for homeostasis. Here, we
establish a co-regulation of purine and pyridine metabolism in response to external adenine
through two separable mechanisms. First, adenine depletion promotes transcriptional upregulation
of the de novo NAD+ biosynthesis genes by a mechanism requiring the key-purine intermediates
ZMP/SZMP and the Bas1/Pho2 transcription factors. Second, adenine supplementation favors the
pyridine salvage route resulting in an ATP-dependent increase of intracellular NAD+. This control
operates at the level of the nicotinic acid mononucleotide adenylyl-transferase Nma1 and can be
bypassed by overexpressing this enzyme. Therefore, in yeast, pyridine metabolism is under the
dual control of ZMP/SZMP and ATP, revealing a much wider regulatory role for these intermediate
metabolites in an integrated biosynthesis network.
DOI: https://doi.org/10.7554/eLife.43808.001
Introduction
Nicotinamide adenine dinucleotide (NAD+/NADH) is a coenzyme mediating hydrogen exchange in a
myriad of metabolic reactions and a co-substrate for several enzymes including the sirtuin protein
deacetylases, Poly (ADP-ribose) polymerase (PARP), and the cyclic ADP-ribose (cADPR)synthases
(Verdin, 2015). In redox reactions, NAD+ and NADH are interconverted with no change in overall
NAD amount. By contrast, NAD+-consuming reactions can affect NAD+ concentration in the cell. In
particular, NAD+ was found to decline with ageing, possibly through limitation of recycling or
increased consumption via PARP (Imai and Guarente, 2014). This decline can be reversed by sup-
plementation with nicotinamide (NAM), its riboside (NR) or mono-nucleotide (NMN) derivatives, that
can result in health improvement and/or extended lifespan, although the underneath mechanisms
are not fully understood (Mitchell et al., 2018; Rajman et al., 2018; Yoshino et al., 2018).
Increased de novo synthesis of NAD+ was also found to improve health (Katsyuba et al., 2018).
However, the potential health-benefits of increasing NAD+ are challenged by recent studies showing
that increased expression of the NAD+ recycling enzyme, NAM phosphoribosyl-transferase
(NAMPT), results in treatment-resistance and invasive phenotypes for melanoma (Ohanna et al.,
2018), glioblastoma (Gujar et al., 2016) and colon cancer (Lucena-Cacace et al., 2018). Hence,
deciphering the mechanisms controlling NAD+ biosynthesis and consumption is fundamental to
understand important biological processes tightly connected to metabolism. In budding yeast,
orthologs of PARP and cADPR synthases have not been identified, but the Sir2 sirtuin proved to be
a key player in conveying NAD+ status as a signal in biological processes such as gene expression
silencing (Moazed, 2001), ageing (Lin and Guarente, 2003) or cell size homeostasis
(Moretto et al., 2013).
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NAD+ biosynthesis requires a nicotinamide moiety (Figure 1—figure supplement 1) that can be
provided through salvage of preformed precursors such as nicotinic acid (NA) or nicotinamide, or
alternatively be the result of de novo synthesis from tryptophan (Figure 1A) (Gazzaniga et al.,
2009). In addition, synthesis of NAD+ (Figure 1A) requires a ribose phosphate (Figure 1—figure
supplement 1), which is incorporated from phosphoribosyl pyrophosphate (PRPP). In yeast, this is
achieved by two distinct phosphoribosyl transferases: Bna6 for the de novo pathway and Npt1 for
the salvage pathway (Figure 1A). The yeast de novo and salvage pathways converge to the precur-
sor NaMN (nicotinic acid mononucleotide) which is then metabolized in two steps to NAD+
(Figure 1A). The first step catalyzes the integration of an AMP molecule to NaMN to form NaAD+
(nicotinic acid adenine dinucleotide), the second consisting in an amination of NaAD+ to generate
NAD+ (Figure 1A). Hence the final NAD+ molecule contains a nicotinamide group, a ribose phos-
phate moiety and an adenine nucleotide (Figure 1—figure supplement 1). In human cells, NAM
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Figure 1. Schematic representation of the yeast pyridine and purine biosynthesis pathways. (A) NAD+ de novo and salvage pathways in yeast. NaAD+:
nicotinic acid adenine dinucleotide; NADP: nicotinamide adenine dinucleotide phosphate; NaMN: nicotinic acid mononucleotide; Pi: inorganic
phosphate; PPi: pyrophosphate and PRPP: 5-phosphoribosyl-1-pyrophosphate. (B) Purine de novo and salvage pathways in yeast. AICAR: 5-amino-4-
imidazole carboxamide ribonucleoside; IMP: inosine 5’-mono-phosphate; SZMP: succinyl-ZMP and ZMP: 5-amino-4-imidazole carboxamide
ribonucleotide 50-phosphate. Red arrows illustrate the (S)ZMP-dependent Bas1/Pho2 interaction leading to the transcriptional regulation of their target
genes. IMP conversion onto either AMP or GMP is common to the de novo and salvage pathways (green box). (A–B) Only the proteins mentioned in
the text are shown (in pink).
DOI: https://doi.org/10.7554/eLife.43808.002
The following figure supplement is available for figure 1:
Figure supplement 1. Chemical structure of NAD+.
DOI: https://doi.org/10.7554/eLife.43808.003
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produced by sirtuins activity is directly recycled to NAD+ via NAMPT, while in budding yeast, recy-
cling of nicotinamide requires its conversion to nicotinic acid (by Pnc1) which is then metabolized to
NaMN by nicotinic acid phosphoribosyl-transferase (Npt1) (Figure 1A). As a matter of fact, NA is
the NAD+ precursor commonly supplied in yeast-defined media.
In yeast the BNA genes, encoding the pyridine de novo pathway enzymes, are transcriptionally
up-regulated when intracellular NAD+ is low (Bedalov et al., 2003). This regulatory process requires
the sirtuin Hst1 which is thought to be a NAD+ sensor. Hst1 associates with the transcription repres-
sor Sum1 directly affecting the expression of the BNA genes (Bedalov et al., 2003). Beside this
feedback repression mechanism, little is known on how yeast cells adapt NAD+ synthesis to growth
conditions and connect it to other metabolic pathways. Here, by studying the physiological response
of yeast cells to purine limitation, we show a tight co-regulation of purine and pyridine metabolism.
NAD+ is one of the most abundant adenylyl-derivative (mM range) in yeast cells (Ashrafi et al.,
2000; Lin et al., 2001; Smith et al., 2000) and as such is highly dependent on purine nucleotide
metabolism for its synthesis. Indeed, as mentioned above, the adenylyl-backbone donor for NAD+ is
ATP (Figure 1A) whose synthesis is dependent on the purine de novo and salvage pathways
(Figure 1B). In yeast, utilization of adenine is preferred to de novo synthesis and availability of ade-
nine in the growth medium results in transcriptional down-regulation of the de novo purine pathway
(Daignan-Fornier and Fink, 1992; Guetsova et al., 1997), as well as increased intracellular ATP
(Gauthier et al., 2008; Saint-Marc et al., 2009). Changes in ATP levels, associated with the avail-
ability of purine precursors, modulate the flux through the purine de novo pathway by allosteric inhi-
bition of the first enzyme of the pathway (Ade4) (Re´bora et al., 2001) (Figure 1B). This feedback
inhibition results in lowering intermediates in the pathway when adenine is available. In particular,
two regulatory metabolites, ZMP (AICAR monophosphate) and its succinyl-precursor SZMP (SAI-
CAR-monophosphate, Figure 1B), collectively named (S)ZMP hereafter, are at least 10 times more
abundant under adenine-free growth conditions than under adenine replete conditions (Daignan-
Fornier and Pinson, 2012; Hu¨rlimann et al., 2011). Importantly, (S)ZMP act as key signals in the
transcriptional activation of several metabolic pathways including purine, histidine, one-carbon units
and phosphate utilization (Pinson et al., 2009; Re´bora et al., 2001; Re´bora et al., 2005; Saint-
Marc et al., 2015). Thus, variation of intracellular ATP, associated with availability of adenine, results
in co-regulation of various metabolic processes. Understanding the consequences of fluctuations of
purine nucleotide levels may thus give important clues on integrative processes resulting in meta-
bolic homeostasis. Here, we reveal a key regulatory crosstalk between ATP and NAD+ biosynthesis
pathways.
Results
Adenine affects abundance of several metabolites involved in NAD+
synthesis
To investigate the physiological consequences of extracellular adenine availability and associated
ATP variations, we compared the metabolic profiles of a wild-type yeast strain grown in the presence
or absence of the preformed purine base adenine (Figure 2—figure supplement 1). A prototrophic
strain was used to ensure that the observed effects do not result from metabolic interferences with
the auxotrophic-markers commonly used to facilitate genetic studies. It should be stressed that dou-
bling time was not affected by adenine feeding, while a significant effect on cell median volume was
observed (Figure 2—figure supplement 2), hence all metabolic quantifications resulting from meta-
bolic profiling were normalized using both cell number and median cell volume.
We first focused our metabolic analysis on highly significant differences (p<0.001). As previously
reported, addition of adenine in the growth medium resulted in a significant increase of intracellular
ATP (Figure 2A) (Gauthier et al., 2008; Saint-Marc et al., 2009) and in a strong diminution of both
ZMP and SZMP (Figure 2B–C) (Hu¨rlimann et al., 2011). Fumarate, a by-product of ZMP synthesis
from SZMP was also decreased when adenine was added (Figure 2D). These results are consistent
with the fact that the flux through the de novo purine pathway is lower in the presence of adenine,
as a result of feedback inhibition of the first step of the pathway (Re´bora et al., 2001). In addition,
adenosine, inosine and guanosine, as well as adenine and hypoxanthine, were more abundant in the
adenine-replete condition revealing an increased interconversion by the salvage pathway of purine
Pinson et al. eLife 2019;8:e43808. DOI: https://doi.org/10.7554/eLife.43808 3 of 23
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Figure 2. NAD+precursors and biosynthesis intermediates respond to variations in extracellular purine availability. The prototrophic wild-type strain FY4
was kept in exponential phase for 24 hr in SDcasaWU medium supplemented (red dots) or not (blue dots) with extracellular adenine. Metabolites were
then extracted and separated by liquid chromatography. Quantifications were determined on independent metabolite extractions (Biological
replicates; N  5) and standard deviation is presented. For each metabolite, the amount measured in cells grown in the presence of adenine (red dots)
was set at 1. Numbers on the top of each panel correspond to the p-value calculated from a Welch’s unpaired t-test.
DOI: https://doi.org/10.7554/eLife.43808.004
The following source data and figure supplements are available for figure 2:
Source data 1. Highly significant metabolic variations for the FY4 prototrophic strain ±adenine.
DOI: https://doi.org/10.7554/eLife.43808.013
Figure supplement 1. Separation of intracellular metabolites by high-performance ion chromatography.
DOI: https://doi.org/10.7554/eLife.43808.005
Figure supplement 2. Adenine supplementation affects cell growth but not cell proliferation.
DOI: https://doi.org/10.7554/eLife.43808.006
Figure supplement 2—source data 1. Median cell volume for the FY4 prototrophic strain grown in glucose medium ±adenine.
Figure 2 continued on next page
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nucleobases and nucleosides (Figure 2E–I). By contrast, several peaks in the chromatograms, includ-
ing the triphosphate nucleotides GTP, CTP and UTP were not significantly affected by adenine sup-
plementation (p>0.05) (Figure 2—figure supplement 3C,J,L). Similarly, pyrimidine derivatives,
except uracil (Figure 2J), were not significantly affected (Figure 2—figure supplement 3G–M).
Finally, five other peaks varied significantly in our metabolic profiling when adenine was added to
the medium (Figure 2K–O). Two of these peaks correspond to tryptophan and nicotinic acid, while
the remaining three were identified as intermediates of the NAD+ de novo synthesis pathway: kynur-
enine, 3-hydroxy-L-kynurenine and 3-hydroxy-anthranilate, (Figure 2—figure supplement 4). These
results thus revealed an effect of adenine feeding on pyridine metabolism. Most importantly, NAD+
itself, the final product of the pathway, was increased by adenine feeding in the prototrophic strain
(Figure 2P; p=0.0015) and in two other reference-strains derived from BY4742 (Figure 2—figure
supplement 5). Altogether these experiments led us to conclude that adenine feeding impacts on
several metabolites directly participating to pyridine metabolism (Figure 1A), including precursors
(tryptophan and nicotinic acid), intermediates (kynurenine, 3-hydroxy-L-kynurenine and 3-hydroxy-
anthranilate), as well as NAD+ itself.
ATP controls NAD+ synthesis
Metabolic profiling in response to adenine feeding revealed a correlation between ATP and NAD+,
raising the possibility that ATP variations in response to adenine could affect intracellular NAD+. To
address more directly this question, we measured NAD+ in yeast mutant strains known to affect
ATP. We first used an adenylate kinase mutant strain (adk1, Figure 1B) known to have reduced intra-
cellular ATP (Gauthier et al., 2008). Indeed, the adk1 knock-out had low ATP (Figure 3A) and most
importantly showed a concomitant low intracellular NAD+ (Figure 3B). On the contrary, a kcs1
mutant, in which ATP production is stimulated (Szijgyarto et al., 2011), had higher ATP (Figure 3A)
and higher NAD+ (Figure 3B). In the same experiment, NADH varied similarly to NAD+ in the adk1
and kcs1 mutants (Figure 3—figure supplement 1) indicating that the synthesis of pyridines rather
than their redox interconversion was altered in these mutants. Of note, the NADH signal being
much noisier than the NAD+ signal, no significant difference was found in response to adenine avail-
ability, a condition leading to small variations of intracellular NAD+. Together these results further
supported the correlation between ATP and NAD+ variations observed in response to adenine feed-
ing. Furthermore, a confirmation came from the use of two additional conditions limiting ATP syn-
thesis through other means. First, we took advantage of a prs3 mutant affecting PRPP-synthetase
the enzyme responsible for providing the nucleotide ribose moiety. The prs3 mutant has a low nucle-
otide content (Hernando et al., 1998), including ATP, but was still highly responsive to the availabil-
ity of the purine base adenine (Figure 3—figure supplement 2A), although PRPP is required both
for salvage and de novo synthesis of ATP (Figure 1B). In this genetic setup, which restricts ATP syn-
thesis because of PRPP shortage, we again found a strong correlation between intracellular ATP and
NAD+ (Figure 3—figure supplement 2A–B). Finally, since intracellular NAD+ responded nicely to
variations of the purine base (adenine) and sugar (PRPP), we asked whether this would be the case
with the third moiety of the ATP nucleotide which is phosphate. In the ATP molecule, the first phos-
phate (alpha) is brought up with the sugar, the second one (beta) is added from pre-existing ATP via
adenylate kinase (Adk1) and the third one (gamma) is added upon glycolysis (fermentation) or
Figure 2 continued
DOI: https://doi.org/10.7554/eLife.43808.007
Figure supplement 3. Quantification of metabolites not or poorly significantly affected by extracellular purine availability.
DOI: https://doi.org/10.7554/eLife.43808.008
Figure supplement 3—source data 1. Non- or lowly-significant metabolic variations in the FY4 prototrophic strain ±adenine.
DOI: https://doi.org/10.7554/eLife.43808.009
Figure supplement 4. Identification of NAD+ de novo pathway intermediates.
DOI: https://doi.org/10.7554/eLife.43808.010
Figure supplement 5. NAD+ and ATP variation in response to adenine availability in wild-type strains.
DOI: https://doi.org/10.7554/eLife.43808.011
Figure supplement 5—source data 1. Metabolic analyses for different wild-type strains grown in ±adenine.
DOI: https://doi.org/10.7554/eLife.43808.012
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Figure 3. ATP controls NAD+level in yeast. (A–B) Intracellular NAD+ varies concomitantly with ATP. Wild-type
(BY4742), adk1 (Y10991) and kcs1 (Y2337) strains were grown in exponential phase for 24 hr in SDcasaWU medium
supplemented (red dots) or not (blue dots) with adenine. The amount of metabolites measured in wild-type cells
grown in the presence of adenine (red dots) was set at 1. (C–D) Nicotinic acid (NA) supplementation leads to an
increase in NAD+ amount in wild-type cells. Cells (wild-type (WT): BY4742, adk1: Y10991 and kcs1: Y2337) were
exponentially grown for 24 hr in SDcasaWU-NA supplemented (green dots) or not (pink dots) with nicotinic acid
(400 mg/l). Metabolite amounts measured in wild-type cells grown in the presence of nicotinic acid were set at 1.
A-D, Metabolite extraction, separation and quantification were performed as in Figure 2. Quantifications were
determined on independent metabolite extractions (N  4) and standard deviation is presented. Numbers on the
top of each panel correspond to the p-values determined by a Welch’s t-test.
DOI: https://doi.org/10.7554/eLife.43808.014
The following source data and figure supplements are available for figure 3:
Source data 1. Metabolic analyses for wild-type, adk1 and kcs1 mutant strains grown ±adenine.
DOI: https://doi.org/10.7554/eLife.43808.027
Source data 2. Metabolic analyses for wild-type, adk1 and kcs1 mutant strains grown ±nicotinic acid.
DOI: https://doi.org/10.7554/eLife.43808.028
Figure supplement 1. NADH varies concomitantly with ATP in adk1 and kcs1 knock-out mutants.
DOI: https://doi.org/10.7554/eLife.43808.015
Figure supplement 1—source data 1. NADH determination in wild-type and mutant strains grown ±adenine.
DOI: https://doi.org/10.7554/eLife.43808.016
Figure supplement 2. Robust correlation between ATP and NAD+variations in diverse ATP-limiting conditions.
DOI: https://doi.org/10.7554/eLife.43808.017
Figure supplement 2—source data 1. Metabolic analyses for wild-type and prs3 mutant strains grown ±adenine.
Figure 3 continued on next page
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oxidative phosphorylation (respiration). Lowering phosphate availability in the growth medium down
to 100 mM resulted in decreased intracellular ATP (Figure 3—figure supplement 2C) and simulta-
neously diminished intracellular NAD+ (Figure 3—figure supplement 2D). We conclude that modify-
ing intracellular ATP by multiple means always resulted in a concomitant variation of intracellular
NAD+.
We then wondered whether the adenine effect on intracellular NAD+ was due to ATP itself, to
the adenylate pool ([AXP]=[ATP] + [ADP] + [AMP]) or to the [ATP]/[AMP] or [ATP]/[ADP] ratios which
are reflected by the adenylate energy charge ([ATP]+1/2 [ADP]/[AXP]) (Atkinson and Walton,
1967). In glucose medium, not surprisingly, adenine feeding had a significant effect on AXP (Fig-
ure 3—figure supplement 3), paralleling increased ATP, which is by far the most abundant adenylic
nucleotide in yeast cells (Ljungdahl and Daignan-Fornier, 2012). However, under the same condi-
tions, adenylate energy charge was only slightly and not very significantly increased (Figure 3—fig-
ure supplement 3). Finally, when cells were grown on non-fermentable carbon sources (glycerol/
ethanol), the same effect of adenine on ATP, AXP and NAD+ was found but no effect on adenylate
energy charge nor cell volume was observed (Figure 3—figure supplement 4). We conclude that
the adenine effect on NAD+ correlates nicely with ATP itself, as well as with AXP, but not with
adenylate energy charge.
Our results revealed a robust correlation between intracellular ATP and NAD+, however, at this
point it was unclear which of these two metabolites was driving the process. Indeed, ATP is required
as a substrate for NAD+ synthesis (Figure 1A) and NAD+ is required during glycolysis at a key step
for ATP synthesis (catalyzed by glyceraldehyde-3-phosphate dehydrogenase). To address this ques-
tion, we first compared intracellular NAD+ and ATP in cells grown with or without nicotinic acid (the
NAD+ precursor commonly supplied in yeast defined media). In the absence of nicotinic acid, intra-
cellular NAD+ was much lower than in cells grown in its presence (Figure 3C). Hence, de novo syn-
thesis alone is not able to sustain high intracellular NAD+ and the contribution of the salvage
pathway is predominant, as previously proposed by Bench and co-workers (Sporty et al., 2009). By
contrast to its effect on NAD+, nicotinic acid depletion had no effect on intracellular ATP
(Figure 3D), demonstrating that a substantial reduction in intracellular NAD+ does not necessarily
reduce intracellular ATP. Strikingly, the same nicotinic acid feeding experiment carried-on with the
low-ATP adk1 mutant showed no effect on intracellular NAD+, which remained low (Figure 3C),
Figure 3 continued
DOI: https://doi.org/10.7554/eLife.43808.018
Figure supplement 2—source data 2. Metabolic analyses for the FY4 strain grown in low and high phosphate
medium.
DOI: https://doi.org/10.7554/eLife.43808.019
Figure supplement 3. Variation of AXP and adenylate energy charge in response to adenine availability.
DOI: https://doi.org/10.7554/eLife.43808.020
Figure supplement 3—source data 1. AXP and adenylic energy charge (AEC) determination for the FY4 prototro-
phic strain ±adenine.
DOI: https://doi.org/10.7554/eLife.43808.021
Figure supplement 4. NAD+, ATP, AXP, adenylate energy charge and median cell volume variations in response
to adenine availability under respiratory conditions.
DOI: https://doi.org/10.7554/eLife.43808.022
Figure supplement 4—source data 1. Metabolic analyses for the FY4 prototrophic strain grown in glycerol/etha-
nol medium ±adenine.
DOI: https://doi.org/10.7554/eLife.43808.023
Figure supplement 4—source data 2. Median cell volume for the FY4 prototrophic strain grown in glycerol/etha-
nol medium ±adenine.
DOI: https://doi.org/10.7554/eLife.43808.024
Figure supplement 5. Stimulation of NAD+synthesis by ATP is abolished in npt1 mutants.
DOI: https://doi.org/10.7554/eLife.43808.025
Figure supplement 5—source data 1. Metabolic analyses for wild-type npt1, kcs1 and npt1 kcs1 mutant strains
grown in the presence of adenine.
DOI: https://doi.org/10.7554/eLife.43808.026
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neither did it affect intracellular ATP (Figure 3D). It thus appears that under these experimental con-
ditions, NAD+ synthesis was highly dependent on intracellular ATP, while the reverse was not
observed. In addition, these results identify the nicotinic acid utilization pathway as the major source
of NAD+ under our experimental conditions. We conclude that ATP stimulates NAD+ synthesis
mostly via the salvage pathway. This conclusion was confirmed by combining a kcs1 mutation,
enhancing ATP production (Figure 3—figure supplement 5A), with a npt1 mutation abolishing
NAD+ synthesis from nicotinic acid (Sandmeier et al., 2002) and resulting in low intracellular NAD+
(Figure 3—figure supplement 5B). Importantly, in the kcs1 npt1 double mutant, intracellular ATP
was high, while intracellular NAD+ was low. Therefore, blocking nicotinic acid utilization, by the npt1
mutation, was sufficient to abolish the ATP stimulation of NAD+ synthesis. Hence, under standard
yeast growth conditions, intracellular NAD+ variations had no effect on ATP while ATP variations
robustly affected intracellular NAD+. Altogether, these data strongly support the idea that ATP con-
trols intracellular NAD+ in yeast.
Yeast cells respond to adenine limitation by turning-on transcription of
the pyridine de novo pathway genes
Adenine depletion, by lowering ATP and increasing intracellular (S)ZMP, is known to transcriptionally
upregulate expression of genes from several pathways including purine, histidine, one-carbon units
and phosphate (Ljungdahl and Daignan-Fornier, 2012). We thus asked whether some of the
observed adenine-dependent metabolic effects could be the result of a transcriptional regulation of
the NAD+ metabolism genes. Revisiting our previous transcriptome data (Hu¨rlimann et al., 2011;
Pinson et al., 2009) revealed an upregulation of the pyridine de novo pathway BNA genes (except
BNA7) under all conditions leading to ZMP and/or SZMP accumulation (Figure 4A, left panel). This
was observed whether (S)ZMP were accumulated from endogenous means (Pinson et al., 2009) or
through addition of the precursor AICAR riboside (sometimes noted AICAr in the literature) to the
growth medium (Hu¨rlimann et al., 2011). In addition, induction of the BNA genes by (S)ZMP was
abolished in strains lacking the transcription factors Bas1 or Pho2 (Figure 4A, right panel), but not in
a strain lacking Pho4 (Figure 4A, right panel). These three transcription factors were previously
found to be responsible for the transcriptional response to ZMP, but only the Bas1/Pho2 pair was
also responsive to SZMP (Pinson et al., 2009). Accordingly, the BNA genes were upregulated in an
ade13 mutant specifically accumulating SZMP (Figure 4A middle panel). By contrast, expression of
the NAD+ salvage pathway genes TNA1 and NPT1 as well as common genes downstream the de
novo and salvage pathways (NMA1, NMA2 and QNS1, see Figure 1A) was not altered by (S)ZMP or
mutations affecting Bas1 and Pho2 (Figure 4A). We conclude that (S)ZMP and the Bas1/Pho2 tran-
scription factors modulate expression of the BNA regulon. This transcriptional regulation by Bas1
and Pho2 in response to adenine limitation was confirmed by northern-blot. Shifting wild-type cells
from an adenine-replete medium to a medium lacking this nucleobase resulted in upregulation of
BNA4 and BNA6 transcripts (Figure 4B, Figure 4—figure supplement 1A), and this upregulation
was abolished in the absence of Bas1 and Pho2 (Figure 4B). In opposite sense, down-regulation of
BNA4 and BNA6 transcripts was found when adenine was added to the growth medium (Figure 4—
figure supplement 1B). These transcriptional responses to adenine were similar to those previously
reported for the ADE17 and PHO84 genes (Gauthier et al., 2008) used as controls (Figure 4B, Fig-
ure 4—figure supplement 1). Importantly, these transcriptional responses resulted in higher amount
of the cognate proteins. Indeed, using GFP-tagged versions of Bna4 and Bna6, we found that these
proteins were more abundant when adenine was absent and that this effect was dependent on Bas1
and Pho2 (Figure 4C–D), just as Ade4-GFP and Ade13, two purine synthesis enzymes used as con-
trols (Figure 4C–D). Together, these results reveal a coordinate transcriptional upregulation of the
pyridine de novo pathway genes, via Bas1/Pho2 and (S)ZMP, in response to purine precursor scar-
city. This regulatory process could modulate the flux in the pathway and account for the decrease of
the de novo pathway precursor (tryptophan) and the increase of pyridine intermediates (kynurenine,
3-hydroxy-L-kynurenine and 3-hydroxy-anthranilate) when cells were grown in the absence of ade-
nine (Figure 2). We thus directly questioned the role of the regulatory metabolite(s) (S)ZMP in this
process.
This was done by comparing the metabolic profile of a wild-type strain with that of an ade16
ade17 double mutant, constitutively accumulating (S)ZMP, and to an ade16 ade17 ade8 his1 quadru-
ple mutant that cannot synthesize (S)ZMP. As anticipated from previous work (Hu¨rlimann et al.,
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Figure 4. Bas1 and Pho2 transcriptionally upregulate the BNA genes in response to (S)ZMP. (A) Heat-map representation of the expression of the
pyridine pathway genes. Results were extracted from our previously reported microarray analyses (Hu¨rlimann et al., 2011; Pinson et al., 2009). Raw
data are available at http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc= GSE13275 and https://www.ncbi.nlm.nih.gov/geo/queryacc.cgi?acc=
GSE29324. (B) Kinetic analysis of ADE17, PHO84 and BNA genes expression in a wild-type and a bas1 pho2 double mutant upon adenine depletion.
Wild-type (BY4742) and bas1 pho2 mutant (Y1487) cells were grown in SDcasaWU + adenine medium, centrifuged for 2 min at 3500 g, washed twice
with SDcasaWU and re-suspended in the same medium lacking adenine (time 0). Aliquots were taken at indicated times, total RNA were extracted and
gene expression was monitored by Northern blotting (N  2). Images shown correspond to one representative experiment. (C–D) Bna4 and Bna6
proteins are more abundant in adenine-depleted conditions in wild-type cells (C) but not in the absence of the Bas1 and Pho2 transcription factors (D).
(C) Wild-type cells harboring either ADE4 (Y11325), BNA4 (Y11328), or BNA6 (Y11327) -GFP fusion at the corresponding gene locus were exponentially
grown for 24 hr in SDcasaWU medium supplemented (+) or not (-) with adenine. (D) Wild-type, bas1 and pho2 yeast strains harboring either ADE4
(Y11325, Y11885 and Y11879), BNA4 (Y11328, Y11894 and Y118887) or BNA6 (Y11327, Y11885 and Y11890) -GFP fusion at the corresponding gene locus
were exponentially grown for 24 hr in SDcasaWAU medium, filtered and then shifted for 2 hr in SDcasaWU medium. (C–D) Total proteins were
extracted, separated by SDS-PAGE, electro-transferred and revealed by western-blotting using anti-GFP (1/500 (C); 1/2,500 (D)), anti-Ade13 (1/1200,000)
Figure 4 continued on next page
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2011), both ZMP and SZMP were low in the wild-type strain, very high in the ade16 ade17 mutant
and not detectable in the quadruple mutant (Figure 5A–B), while ATP was not significantly different
in the three strains (Figure 5C). Tryptophan, the initial substrate of the de novo pyridine pathway,
was significantly lower in the (S)ZMP accumulating ade16 ade17 mutant (Figure 5D) and, at the
same time, all measurable intermediates of the pathway were higher (Figure 5E–F) confirming an
increased metabolic flux under conditions where (S)ZMP are high and transcription of the pathway
genes is stimulated. Furthermore, addition of AICAR, the riboside precursor of ZMP, in the ade16
ade17 ade8 his1 mutant resulted in a dose-dependent accumulation of ZMP as well as SZMP, kynur-
enine, 3-hydroxy-L-kynurenine and 3-hydroxy-anthranilate (Figure 5G–K), while intracellular trypto-
phan was concomitantly decreased (Figure 5L). These results establish that (S)ZMP is necessary and
sufficient to increase consumption of tryptophan and intracellular levels of intermediates of the
NAD+ de novo pathway. This (S)ZMP-dependent regulation recapitulated several of the metabolic
variations observed in response to adenine shortage (compare Figures 2B–C,K,M–O and
Figure 5G–L). Importantly, under conditions where the pyridine salvage pathway is functional, when
external nicotinic acid is plentiful, (S)ZMP accumulation had no effect on intracellular NAD+
(Figure 5M) and no effect on intracellular nicotinic acid (Figure 5N), which is the precursor for the
preferred NAD+ synthesis route in yeast (see Figure 3C, Figure 3F) (Sporty et al., 2009). However,
in nicotinic-acid-free medium, intracellular NAD+ was increased in the ade16 ade17 mutant (Fig-
ure 5—figure supplement 1A), which accumulated ZMP (Figure 5—figure supplement 1B), while
intracellular ATP was not significantly affected (Figure 5—figure supplement 1C). Accordingly,
when the utilization of nicotinic acid was blocked by a npt1 knock-out mutation, intracellular NAD+
was significantly higher in cells grown in the absence of adenine (Figure 5O), condition where (S)
ZMP were high (Figure 5P–Q) and the pyridine de novo pathway genes up-regulated (Figure 4). We
conclude that, in the absence of adenine, the pyridine de novo pathway is transcriptionally upregu-
lated via a mechanism depending on (S)ZMP and Bas1/Pho2. However, with regard to NAD+ status,
this effect is masked when nicotinic acid is abundant and the salvage pathway is active since the con-
tribution of the salvage pathway is preponderant for NAD+ synthesis in yeast (Sporty et al., 2009)
and appears to be stimulated by ATP.
ATP affects nicotinic acid utilization
As revealed above, in spite of up-regulation of the pyridine de novo pathway, increased intracellular
(S)ZMP did not account for intracellular variation of nicotinic acid and NAD+ in response to adenine
shortage under standard growth conditions when NA is plentiful (compare Figure 2L,P and
Figure 5M–N). Accordingly, we found that intracellular NAD+ was still responsive to adenine in the
bna2 or bna6 mutants (Figure 6—figure supplement 1) blocking the first and last step of the de
novo pathway, respectively; hence establishing that the flux in the de novo pathway is not strictly
required for increased NAD+ in response to adenine.
These observations prompted us to further characterize the effects of adenine on pyridine sal-
vage. We first asked whether adenine could impact intracellular nicotinic acid via its effect on ATP.
To mimic the higher intracellular ATP observed in adenine-replete cells, we took advantage of the
kcs1 mutant strain that has elevated ATP (Szijgyarto et al., 2011), even in the absence of adenine
(Figure 6A). In the kcs1 mutant, intracellular nicotinic acid was low and was not affected by adenine
Figure 4 continued
and anti-Pgk1 (1/50,000) antibodies. Ade4-, Bna4- and Bna6-GFP fusions proteins were revealed at 84, 79 and 60 kDa, respectively. Images shown
correspond to one representative experiment (N  2).
DOI: https://doi.org/10.7554/eLife.43808.029
The following source data and figure supplements are available for figure 4:
Source data 1. Northern blot quantification for wild-type and bas1 pho2 mutant strains shifted in adenine-depleted medium.
DOI: https://doi.org/10.7554/eLife.43808.032
Figure supplement 1. Kinetic analysis of ADE17, PHO84 and BNA genes expression upon either external adenine depletion (A) or addition (B).
DOI: https://doi.org/10.7554/eLife.43808.030
Figure supplement 1—source data 1. Northern blot quantification for the wild-type strain shifted in either adenine-depleted or adenine-replete
medium.
DOI: https://doi.org/10.7554/eLife.43808.031
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Figure 5. (S)ZMP-increase is sufficient to stimulate the NAD+ de novo pathway. (A–F) (S)ZMP accumulation in the ade16 ade17 mutant is associated to
a significant increase in NAD+ de novo pathway intermediates. Wild-type (BY4742, red dots), ade16 ade17 (Y1162, green dots) and ade16 ade17 ade8
his1 (quad; Y2950, grey dots) were grown in SDcasaWAU medium. (G– L) Accumulation of ZMP achieved by external AICAR addition correlates with
increasing amounts of NAD+ de novo pathway intermediates. The ade16 ade17 ade8 his1 quadruple mutant strain (Y2950) was grown in SDcasaWAU
medium and incubated for 24 hr with indicated amounts of AICAR prior to metabolite extraction. (M–N) (S)ZMP accumulation has no significant effect
on NAD+ and nicotinic acid levels when the salvage pathway is active. NAD+ and nicotinic acid levels were determined from the experiment described
in Figure 5A–F. (O–Q) Upregulation of the purine de novo pathway in the absence of adenine, when (S)ZMP is high, results in higher intracellular NAD+
only when the pyridine salvage pathway is inactivated. Wild-type (BY4742) and npt1 knock-out (Y5581) strains were exponentially grown for 24 hr in
SDcasaWU medium ±Adenine. (A–F, M–Q) Quantifications were determined from independent metabolite extractions (N = 5). Error bars correspond to
standard deviation and indicated p-values were calculated from a Welch’s t-test.
DOI: https://doi.org/10.7554/eLife.43808.033
The following source data and figure supplements are available for figure 5:
Source data 1. Metabolic analyses for wild-type and ade16 ade17-derived mutant strains grown in +adenine.
DOI: https://doi.org/10.7554/eLife.43808.036
Source data 2. Metabolic analyses for the ade16 ade17 ade8 his1 mutant strain grown in various amount of AICAR.
DOI: https://doi.org/10.7554/eLife.43808.037
Source data 3. Metabolic analyses for wild-type and npt1 mutant strains grown in ±adenine.
DOI: https://doi.org/10.7554/eLife.43808.038
Figure 5 continued on next page
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limitation (Figure 6B), strongly suggesting that ATP enhances nicotinic acid utilization. Indeed, in
the kcs1 mutant as well as in the wild-type strain, there is an inverse correlation between intracellular
ATP and nicotinic acid (Figure 6A–B). We propose that ATP is critical for nicotinic acid utilization in
yeast in response to adenine availability
To clarify how intracellular nicotinic acid is affected by adenine feeding, we measured intracellular
nicotinic acid in a npt1 mutant blocking nicotinic acid utilization (Sandmeier et al., 2002). In the
npt1 mutant, intracellular nicotinic acid was increased compared to wild-type and most importantly
was no longer affected by adenine (Figure 6C) in contrast to ATP (Figure 6D). This observation
established that adenine affected utilization of intracellular nicotinic acid rather than its uptake. This
conclusion was further confirmed by using a growth medium lacking nicotinic acid and by providing
the cells with nicotinamide, a precursor of nicotinic acid (Figure 1A). Under such growth conditions,
intracellular nicotinic acid was significantly lower in adenine-replete wild-type cells (Figure 6—figure
supplement 2); that is when intracellular ATP was higher. Importantly, under these growth condi-
tions, the adenine-effect was abolished in the absence of Npt1 (Figure 6—figure supplement 2).
Hence, the effect of adenine on nicotinic acid accumulation was still observed when nicotinamide
was used as a precursor, establishing that adenine affects nicotinic acid utilization. Furthermore, the
‘adenine-effect’ was also abolished in the ‘high-ATP’ kcs1 mutant (Figure 6—figure supplement 2),
confirming that intracellular ATP most certainly plays a crucial role in nicotinic-acid-utilization
efficiency.
Altogether, our data establish that ATP regulates NAD+ metabolism by two different mecha-
nisms. First, in the absence of adenine, the pyridine de novo pathway is affected in a (S)ZMP-depen-
dent way and second, in the presence of adenine, when ATP is higher, it stimulates nicotinate
utilization by the salvage pathway in a ZMP-independent way.
Nicotinic acid mononucleotide adenylyl-transferase Nma1 controls
synthesis of NAD+
To identify the most limiting step(s) in NAD+ synthesis when ATP is lowered, we overexpressed the
individual NAD+ salvage pathway genes (Figure 1A) in a wild-type strain grown in the absence of
adenine. Overexpression of NPT1 had no effect on intracellular NAD+ (Figure 7A), while overexpres-
sion of NMA1, but not NMA2, significantly increased NAD+ level (Figure 7A). Finally, overexpression
of QNS1 encoding the last step of NAD+ synthesis had no effect (Figure 7A). Of note, intracellular
ATP was not affected by expression of the various genes (Figure 7B). We conclude that overexpres-
sion of NMA1 is sufficient to stimulate NAD+ synthesis. The preeminent role of NMA1 over NMA2 in
NAD+ synthesis was confirmed by studying the corresponding knock-out mutants. Indeed, the nma1
mutant was much more affected than the nma2 mutant for NAD+ synthesis (as previously shown by
Lin and coworkers (Croft et al., 2018)), while intracellular ATP was not affected (Figure 7C–D). The
variation of intracellular NAD+ in response to adenine was non-significant in the nma1 mutant
(Figure 7C) but was still observed upon NMA1 overexpression (Figure 7E), while both conditions
had no effect on intracellular ATP (Figure 7D,F). Together, these results establish that NAD+ synthe-
sis can be efficiently enhanced by NMA1 overexpression, while it is strongly affected in the nma1
mutant, thus revealing Nma1 as a major actor in this regulatory process.
Interestingly, metabolic profiling of the strain overexpressing NPT1 allowed the identification of a
previously unidentified peak as NaMN (nicotinic acid mononucleotide) (Figure 7—figure supple-
ment 1A), which is both the product of Npt1 and the substrate for Nma1/Nma2 (Figure 1A). Simi-
larly, overexpression of NMA1 allowed the identification of the peak corresponding to NaAD+
(nicotinic acid adenine dinucleotide) (Figure 7—figure supplement 1B) the product of Nma1/Nma2
and the substrate for Qns1 (Figure 1A). Accumulation of NaMN, but not NaAD+, upon Npt1 overex-
pression indicated that the downstream enzymatic step (catalyzed by Nma1/Nma2) is limiting when
Figure 5 continued
Figure supplement 1. NAD+ level is significantly increased in the ade16 ade17 (S)ZMP accumulating mutant in the absence of external nicotinic acid.
DOI: https://doi.org/10.7554/eLife.43808.034
Figure supplement 1—source data 1. Metabolic analyses for wild-type and ade16 ade17 mutant strains grown in NA-free medium.
DOI: https://doi.org/10.7554/eLife.43808.035
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Figure 6. Metabolization of nicotinic acid is tightly connected to the amount of ATP. Nicotinic acid utilization is
increased when ATP is higher (A–B) and not anymore affected by extracellular adenine in a npt1 mutant (C–D). (A–
D) Wild-type (BY4742; (A–D) and either kcs1 (Y2337; A–B) or npt1 (Y5581; C–D) knock-out mutant strains were
exponentially grown for 24 hr in SDcasaWU medium supplemented (red dots) or not (blue dots) with adenine.
Quantifications were determined from independent metabolite extractions (N  3) and standard deviation is
presented. For each metabolite, the amount measured in wild-type cells grown in the presence of adenine was set
at one and indicated p-values were calculated from a Welch’s t-test.
DOI: https://doi.org/10.7554/eLife.43808.039
The following source data and figure supplements are available for figure 6:
Source data 1. Metabolic analyses for wild-type and kcs1 mutant strains grown in ±adenine.
DOI: https://doi.org/10.7554/eLife.43808.044
Source data 2. Nicotinic acid and ATP determination for wild-type and npt1 mutant strains grown in ±adenine.
DOI: https://doi.org/10.7554/eLife.43808.045
Figure supplement 1. NAD+variations in response to external adenine availability do not require a functional
pyridine de novo pathway.
DOI: https://doi.org/10.7554/eLife.43808.040
Figure supplement 1—source data 1. Metabolic analyses for bna2 and bna6 mutant strains grown in ±adenine.
DOI: https://doi.org/10.7554/eLife.43808.041
Figure 6 continued on next page
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Npt1 is overexpressed thus explaining why overexpression of Npt1 did not increase intracellular
NAD+. By contrast, NMA1 overexpression resulted in both higher NaAD+ and NAD+ indicating that
the downstream step catalyzed by Qns1 was not limiting for NAD+ synthesis under these conditions.
Strikingly, we observed that NaMN accumulation resulting from Npt1 overexpression was greater
when ATP was lower, that is when cells were grown in the absence of adenine, while at the same
time intracellular NAD+ was low (Figure 7—figure supplement 2). This observation, together with
the Nma1 overexpression results (Figure 7A,C), establish that the Nma1/Nma2 catalyzed step is a
bottleneck for NAD+ synthesis in particular when ATP is lower. Most importantly, this bottleneck,
revealed by overexpression experiments, operates in wild-type prototrophic yeast cells in response
to nutrient availability. Indeed, intracellular NaMN was found more abundant in a prototrophic strain
grown in the absence of adenine compared to the same strain grown in its presence (Figure 8A).
Furthermore, in the same experiment, intracellular NaAD+ was higher when adenine was added to
the growth medium (Figure 8B) a condition resulting in ‘high’ NAD+ and ATP (Figure 8C–D). These
results demonstrate that nicotinic acid mononucleotide adenylyltransferase is limiting for NAD+ syn-
thesis especially under conditions in which ATP is low. Similar results were obtained with a bna2
mutant strain, establishing that this regulation process does not require a functional de novo path-
way (Figure 8—figure supplement 1). We conclude that ATP and Nma1 jointly control NAD+ syn-
thesis from nicotinic acid in the pyridine salvage pathway.
Discussion
In this work, we used adenine supplementation to modulate purine metabolism and uncovered a
robust effect on pyridine synthesis. In particular, we showed concomitant increase of several NAD+
de novo synthesis intermediates when adenine was absent and an enhanced decrease of the precur-
sor tryptophan, hence establishing that the de novo pathway is upregulated under these conditions
(Figure 8E). By contrast, the pyridine salvage pathway was stimulated under adenine-replete condi-
tions (Figure 8F), as indicated by lower amount of the salvage precursor nicotinic acid. It should be
stressed that synthesis of NaMN from nicotinic acid is at the cost of an ATP molecule while synthesis
of NaMN from tryptophan does not consume ATP (Figure 1A). Our data show that when ATP is
lower, yeast cells stimulate NaMN synthesis via the de novo route which is less ATP-requiring
(Figure 8E–F). Using various combinations of growth conditions and mutants, we established that
adenine depletion acted, via high (S)ZMP, to transcriptionally up-regulate the NAD+
de novo pathway genes (Figure 8E). This regulatory process required the transcription factors Bas1p
and Pho2p, the interaction of which is known to be directly enhanced by (S)ZMP in vivo
(Pinson et al., 2009). This result is in good agreement with chromatin immunoprecipitation results
from the Petes’ laboratory showing that Bas1 was bound to the promoters of the BNA2 and BNA6
genes (Mieczkowski et al., 2006). This finding thus extends our understanding of the adenine tran-
scriptional regulon and establishes co-regulation of the pyridine de novo pathway with purine, histi-
dine, glutamine and one carbon units pathways which are all responding to adenine availability via
Bas1, Pho2 and (S)ZMP (Ljungdahl and Daignan-Fornier, 2012). In parallel, we found that intracellu-
lar ATP was also critical for NAD+ synthesis independently of the de novo pathway and its activation
by (S)ZMP. This critical role for ATP in NAD+ synthesis resulted in enhanced assimilation of nicotinic
acid and higher intracellular NAD+. Together our results point to a purine/pyridine inter-pathway
regulation involving both (S)ZMP (Figure 8E) and ATP (Figure 8F). The two responses appear quite
distinct, as they can be separated by specific mutations, although they co-exist upon adenine sup-
plementation conditions in wild-type cells. Thus, NAD+-synthesis integrates three metabolic
Figure 6 continued
Figure supplement 2. Nicotinic acid variations in response to external adenine availability are abolished in npt1
and kcs1 mutants fed with nicotinamide.
DOI: https://doi.org/10.7554/eLife.43808.042
Figure supplement 2—source data 1. Metabolic analyses for wild-type, npt1 and kcs1 mutant strains grown in
NA-free medium supplemented with nicotinamide ±adenine.
DOI: https://doi.org/10.7554/eLife.43808.043
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Figure 7. Nicotinic acid mononucleotide adenylyl transferase activity limits NAD+ synthesis. (A–B) Overexpression
of NMA1 is sufficient to increase NAD+ content when cells are grown in the absence of adenine. Wild-type cells
(BY4742) were transformed with plasmid allowing overexpression (OE) of the indicated pyridine salvage pathway
genes or the empty vector (No). Transformants were grown in SDcasaWU medium lacking adenine. Values
obtained with the empty vector were set at 1. (C–D) NAD+ does not respond to adenine availability in cells lacking
NMA1. Wild-type cells (BY4742) and nma mutants (nma1: Y5662; nma2: Y5663) strains were grown in SDcasaWU
medium lacking (blue dots) or not (red dots) adenine. Values obtained in the wild-type strain grown in the
presence of adenine were set at 1. (E–F) Overexpression of NMA1 leads to increased intracellular NAD+. Wild-
type cells (BY4742) were transformed with a plasmid allowing overexpression (OE) of NMA1 gene or the empty
vector (No). Transformants were grown in SDcasaWU medium lacking (blue dots) or not (red dots) adenine. Values
obtained with the empty vector in the presence of adenine were set at 1. (A–F) Quantifications were determined
independent metabolite extractions (N  4) and standard deviation is presented. Indicated p-values were
calculated from a Welch’s t-test.
DOI: https://doi.org/10.7554/eLife.43808.046
The following source data and figure supplements are available for figure 7:
Figure 7 continued on next page
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parameters ZMP (via Bas1 Pho2), ATP (via Nma1) and NAD+ itself (via Hst1); each of these parame-
ters weighing on the final outcome in response to internal and external environment.
How does ATP affect NAD+ abundance? Importantly, the adenine-effect on intracellular NAD+
was still found in mutants blocking the pyridine de novo pathway indicating that an important part
of the adenine-effect is driven through the salvage pathway. Our results revealed an inverse correla-
tion between intracellular ATP and nicotinic acid, thus pointing to nicotinic acid utilization as a limit-
ing step in the NAD+ synthesis when ATP is decreased. NAD+ synthesis from nicotinic acid is the
result of three enzymatic steps, each consuming an ATP molecule, although very differently
(Figure 1A). The first step is catalyzed by nicotinic acid phosphoribosyl transferase (Npt1), an
enzyme belonging to the family of phosphoribosyl transferases that transfer a ribose phosphate
from PRPP to a specific substrate. Strikingly, among yeast phosphoribosyl transferases, Npt1 is the
only one known to necessitate ATP. Yet, ATP is not used as a co-substrate in the Npt1 catalyzed
reaction but it is required to phosphorylate a key histidine residue in the enzyme and thereby to
stimulate NaMN formation (Rajavel et al., 1998). The allosteric constant for ATP measured in vitro is
around 70 mM (Hanna et al., 1983) and cannot simply account for the differences of substrate accu-
mulation observed in vivo in response to intracellular ATP (mM range). Based on intracellular nico-
tinic acid measurements in the presence and absence of adenine, nicotinic acid metabolism via Npt1
appeared reduced when adenine was absent and ATP was lower. In the meantime, NPT1 overex-
pression experiments resulted in accumulation of the reaction product NaMN. However, NPT1 over-
expression had no effect on intracellular NAD+, while NMA1 overexpression was sufficient to
significantly increase intracellular NAD+. Importantly, the effect of NMA1 overexpression on intracel-
lular NAD+ was found even when ATP was low (in the absence of adenine). Nma1 catalyzes the
incorporation of an entire AMP molecule in the NaMN precursor resulting in synthesis of NaAD+
(Figure 1A). Of note, only the double nma1 nma2 mutant is lethal under standard yeast growth con-
ditions (Kato and Lin, 2014) indicating that both isoforms contribute to the activity although Nma1
appears prevalent (Croft et al., 2018). This step is clearly critical in terms of net purine consumption
since the ATP molecule involved in this reaction is incorporated as a substrate and thus not recycled.
The two enzymes have very different Km for ATP in vitro (0.1 and 1.4 mM for Nma1 and Nma2,
respectively (Emanuelli et al., 2003)) and, according to single mutant analysis, Nma1 contribution to
the regulatory process appears much higher than that of Nma2 (Figure 7). Based on overexpression
studies and analyses of intracellular NaMN and NaAD+, we established that Nma1 is controlling
NAD+ synthesis in response to adenine feeding and ATP variations. However, the Km for ATP of
Nma1 (0.1 mM) is way below the intracellular ATP concentration (several mM), even in the absence
of adenine. Hence, this catalytic constant measured in vitro cannot simply explain how ATP and
Nma1 act conjointly to ensure NAD+ homeostasis. More complex mechanisms such as allosteric
Figure 7 continued
Source data 1. Metabolic analyses for the wild-type strain overexpressing various NAD+-synthesis genes and
grown in - adenine.
DOI: https://doi.org/10.7554/eLife.43808.051
Source data 2. Metabolic analyses for wild-type, nma1 and nma2 mutant strains grown in ±adenine.
DOI: https://doi.org/10.7554/eLife.43808.052
Source data 3. Metabolic analyses for the wild-type strain overexpressing NMA1 and grown in ±adenine.
DOI: https://doi.org/10.7554/eLife.43808.053
Figure supplement 1. NaMN and NaAD+are increased in response to NPT1 and NMA1 genes overexpression,
respectively.
DOI: https://doi.org/10.7554/eLife.43808.047
Figure supplement 1—source data 1. NaMN and NaAD+ determination in the wild-type overexpressing various
NAD+-synthesis genes and grown in - adenine.
DOI: https://doi.org/10.7554/eLife.43808.048
Figure supplement 2. Accumulation of NaMN in response to NPT1 overexpression is higher when ATP is limiting.
DOI: https://doi.org/10.7554/eLife.43808.049
Figure supplement 2—source data 1. Metabolic analyses for the wild-type overexpressing NPT1 and grown
in ±adenine.
DOI: https://doi.org/10.7554/eLife.43808.050
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regulation and/or post-translational modification are more likely to operate. Finally, the third step
catalyzed by Qns1 requires ATP as a co-factor but did not appear to play a major role in ATP control
of NAD+ synthesis as revealed by overexpression and metabolic analyses. It should be stressed that
intracellular NAD+ concentration is in the same range as that of ATP (mM) and thus NAD+ synthesis
most probably very significantly weigh on ATP backbone consumption. Because NAD+ metabolism
is tightly linked to major biological processes such as aging (Lin and Guarente, 2003) or cell size
homeostasis (Moretto et al., 2013), the direct impact of ATP on intracellular NAD+ reported here
will certainly open new perspectives in these fields. Strikingly, the adenine-effects on ATP and NAD+
did not affect generation time under exponential growth, hence illustrating how metabolic plasticity
can ensure proliferation robustness. However, the new metabolic balance associated with purine
precursor availability was accompanied by variations of cell volume and hence biomass production.
In a previous work (Moretto et al., 2013), we documented a negative effect of nicotinic acid on cell
volume but this was done under conditions where ATP was ‘low’ (in the absence of adenine) and
constant. Cell size decrease under these conditions could reflect metabolic competition for PRPP,
the synthesis of which is critical for cell size homeostasis (Jorgensen et al., 2002). It thus seems that
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Figure 8. Yeast co-regulates purine and pyridine metabolism in response to adenine through two mechanisms. (A–D) The Nma1-bottleneck for NAD+
synthesis operates under physiological conditions. A prototrophic strain (FY4) was grown in SDcasaWU medium lacking (blue dots) or not (red dots)
adenine. Values obtained in the presence of adenine (red dots) were set at one for each metabolite. Quantifications were determined from
independent metabolite extractions (N  7). Standard deviation is presented and a Welch’s t-test was used to calculate the indicated p-values. (E–F)
Model of NAD+ synthesis rerouting in response to extracellular adenine availability. The thickness of lines and arrows refers to the intensity of signaling
or flux in metabolic pathways. For each metabolite, the font-size reflects variation of its intracellular content.
DOI: https://doi.org/10.7554/eLife.43808.054
The following source data and figure supplements are available for figure 8:
Source data 1. Determination of pyridine-pathway intermediates in the FY4 prototrophic strain ±adenine.
DOI: https://doi.org/10.7554/eLife.43808.057
Figure supplement 1. Modulation of adenine on NAD+biosynthesis operates in the absence of a functional de novo pathway.
DOI: https://doi.org/10.7554/eLife.43808.055
Figure supplement 1—source data 1. Pyridine pathway intermediates determination for the bna2 mutant strain ±adenine.
DOI: https://doi.org/10.7554/eLife.43808.056
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both purine (ATP) and pyridine (NAD+) levels are contributing to the complex cell size trait. Strik-
ingly, when cells were grown on ethanol/glycerol as carbon sources, adenine feeding had no effect
on cell size while the same effects as for glucose were found on intracellular ATP and NAD+. These
results establish that cell size variations, although highly dependent on the medium richness, are not
simply correlated to the cell content for these two key metabolites.
Based on results presented here, we propose a model (Figure 8E–F) in which synthesis of NAD+
in yeast cells respond to adenine availability through a dual process involving dedicated regulatory
molecules (S)ZMP and ATP. In the absence of adenine, ATP is ‘low’ and (S)ZMP are ‘high’ resulting
in transcriptional activation of the BNA genes of the de novo pathway while downstream synthesis
of NAD+ is limited by intracellular ATP at the Nma1/2 step. Under adenine replete conditions, where
ATP is ‘high’ and (S)ZMP ‘low’, the pyridine salvage pathway is favored and the Nma1/2 bottleneck
is loosened, resulting in higher intracellular NAD+. This regulatory role of (S)ZMP in several pathways
could reflect the fact that the de novo pathways might be favored in the wild under low-nutrient con-
ditions, that is when purine and pyridine precursors such as adenine and nicotinic acid are likely con-
comitantly low. Indeed, in the same low-nutrient conditions, phosphate utilization genes (the PHO
regulon) are stimulated at the transcriptional level in response to ZMP (Pinson et al., 2009). Hence,
the purine metabolic intermediates (S)ZMP stimulate transcription of the purine (ADE) and pyridine
(BNA) de novo pathway genes via the transcription factors Bas1 and Pho2 and also stimulates the
phosphate utilization (PHO) genes via the transcription factors Pho4 and Pho2. We propose that (S)
ZMP perform as a general transcriptional signal in response to purine shortage reflecting the likely
broader nutrient limitation encountered by yeast cells in their natural environment when purine pre-
cursors are scarce. (S)ZMP would thereby contribute to inform the cells on their nutrient status.
Accordingly, we observed that yeast cells transferred from a poor to rich nutrient medium have a
much longer adaptation time (lag) when (S)ZMP are high, although their doubling time following the
lag was not affected (Ceschin et al., 2015). In parallel to this (S)ZMP transcriptional response, we
propose that ATP itself would be sensed by strategic metabolic enzymes and would thereby directly
affect cell metabolism by modulating synthesis of key metabolites such as NAD+, inositol polyphos-
phates or (S)ZMP. These metabolites would in turn, directly (ZMP for Bas1/Pho2 and Pho4/Pho2) or
indirectly (NAD+ for Hst1/Sum1; IP7 for Pho81/Pho80-Pho85/Pho4) modulate specific transcription
factors. While our work revealed strong co-regulation processes between purine and pyridine
metabolisms, further regulatory interconnections between purine and phosphate pathways as well
as pyridine and phosphate pathways had been reported previously (Auesukaree et al., 2005;
Choi et al., 2017; Gauthier et al., 2008; Huang and O’Shea, 2005; Lu and Lin, 2011;
Pinson et al., 2009) hence unveiling the complexity of inter-regulatory processes between these
three metabolic pathways. In conclusion, in the model proposed here, (S)ZMP act as a general tran-
scriptional signal for purine shortage, while specific metabolites from each pathway would serve to
signal ATP profusion. Whether this concerted cellular response to ATP status extends to other meta-
bolic pathways or cellular functions remains to be explored as well as its conservation in other
species.
Materials and methods
Yeast media and strains
SD is a synthetic minimal medium containing 0.5% ammonium sulfate, 0.17% yeast nitrogen base
(BD-Difco; Franklin Lakes, NJ, USA), 2% glucose. SDcasaW is SD medium supplemented with 0.2%
casamino acids (#233520; BD-Difco; Franklin Lakes, NJ) and tryptophan (0.2 mM). When indicated,
adenine (0.3 mM), and/or uracil (0.3 mM) were added in SDcasaW medium resulting in media named
SDcasaWA (+adenine), SDcasaWU (+uracil) and SDcasaWAU (+adenine + uracil). SDcasaW-NA
medium is SDcasaW medium prepared with 0.67% yeast nitrogen base without nicotinic acid but
containing ammonium sulfate (#CYN3901; Formedium, Hunstanton, UK). When required, this
medium was supplemented with 400 mg/l of nicotinic acid or 1 mM nicotinamide. SGE is a synthetic
minimal medium containing 0.5% ammonium sulfate, 0.17% yeast nitrogen base (BD-Difco; Franklin
Lakes, NJ), 2% glycerol and 2% Ethanol. Yeast strains are listed in Table 1 and belong to, or are
derived from, a set of knock-out mutant strains isogenic to BY4742 purchased from Euroscarf
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(Frankfurt, Germany). Multi-mutant strains were obtained by crossing, sporulation and micromanipu-
lation of meiosis progeny. The prototrophic FY4 strain was described in Winston et al. (1995).
Plasmids
Plasmids allowing overexpression of NAD+-salvage pathway genes under the control of a tetracy-
cline repressible promoter were obtained by PCR amplification on genomic DNA from the FY4 strain
with the following pairs of oligonucleotides: NPT1: oligonucleotides 5’- CGCGGATCCACCATGTCA-
GAACCAGTGATAAAG-3’ and 5’- ACGTCTGCAGTTAGGTCCATCTGTGCGCTTC-3’; NMA1: oligo-
nucleotides 5’- CGCAGATCTAACATGGATCCCACAAGAGC-3’ and 5’- ACGTCCTGCAGGTCATTC
TTTGTTTCCAAGAAC-3’; NMA2: oligonucleotides 5’- CGCAGATCTGTAATGGATCCCACCAAAGC-
3’ and 5’- ACGTCTGCAGTCACTCTTTGCTATCCAAGAC-3’ and QNS1: oligonucleotides 5’-
CGCGGATCCGTAATGTCACATCTTATCAC-3’ and 5’- ACGTCCTGCAGGCTAATCAATAGACATAA
TGTC-3’. PCR products were digested with BamHI and PstI (For NPT1 and NMA2), BglII and SbfI
(NMA1) or BamHI and SbfI (QNS1) and were all cloned in the pCM189 (Garı´ et al., 1997) vector
digested with BamHI and PstI, resulting in plasmids named p4130, p4126, p4234 and p4124 for tet-
NPT1, tet-NMA1, tet-NMA2, and tet-QNS1, respectively.
Table 1. List of the yeast strains used in this study.
Strain name Genotype
BY4742 MATa his3D1 leu2D0 lys2D0 ura3D0
FY4 MATa
Y286 MATa his3D1 leu2D0 lys2D0 ura3D0
Y1162 MATa ade16::kanMX4 ade17::kanMX4 his3D1 leu2D0 ura3D0
Y2337 MATa his3D1 leu2D0 lys2D0 ura3D0 kcs1::kanMX4
Y1487 MATa his3D1 leu2D0 ura3D0 met15D0 bas1::kanMX4 pho2::kanMX4
Y2950 MATa his3D1 leu2D0 ura3D0 ade16::kanMX4 ade17::kanMX4 ade8::kanMX4 his1::kanMX4
Y4835 MATa prs3::KanMX4 his3D1 leu2D0 ura3D0
Y5581 MATa his3D1 leu2D0 lys2D0 ura3D0 npt1::kanMX4
Y5662 MATa his3D1 leu2D0 lys2D0 ura3D0 nma1::kanMX4
Y5663 MATa his3D1 leu2D0 lys2D0 ura3D0 nma2::kanMX4
Y5731 MATa his3D1 leu2D0 ura3D0 nma1::kanMX4
Y5822 MATa his3D1 leu2D0 lys2D0 ura3D0 bna4::kanMX4
Y5891 MATa his3D1 leu2D0 lys2D0 ura3D0 bna6::kanMX4
Y10838 MATa his3D1 leu2D0 lys2D0 ura3D0 bna2::kanMX4
Y10901 MATa his3D1 leu2D0 lys2D0 ura3D0 bna1::kanMX4
Y10903 MATa his3D1 leu2D0 lys2D0 ura3D0 bna5::kanMX4
Y10904 MATa his3D1 leu2D0 lys2D0 ura3D0 bna7::kanMX4
Y10991 MATa his3D1 leu2D0 ura3D0 adk1::kanMX4
Y11017 MATa his3D1 leu2D0 lys2D0 ura3D0 npt1::kanMX4 kcs1::kanMX4
Y11325 MATa his3D1 leu2D0 ura3D0 met15D0 ADE4-GFP-HIS3
Y11327 MATa his3D1 leu2D0 ura3D0 met15D0 BNA6-GFP-HIS3
Y11328 MATa his3D1 leu2D0 ura3D0 met15D0 BNA4-GFP-HIS3
Y11879 MATa pho2::KanMX4 his3D1 leu2D0 ura3D0 met15D0 ADE4-GFP-HIS3
Y11885 MATa bas1::KanMX4 his3D1 leu2D0 ura3D0 met15D0 ADE4-GFP-HIS3
Y11887 MATa pho2::KanMX4 his3D1 leu2D0 ura3D0 met15D0 BNA4-GFP-HIS3
Y11890 MATa pho2::KanMX4 his3D1 leu2D0 ura3D0 met15D0 BNA6-GFP-HIS3
Y11894 MATa bas1::KanMX4 his3D1 leu2D0 ura3D0 met15D0 BNA4-GFP-HIS3
Y11895 MATa bas1::KanMX4 his3D1 leu2D0 ura3D0 met15D0 BNA6-GFP-HIS3
DOI: https://doi.org/10.7554/eLife.43808.058
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Metabolite extraction and separation by liquid chromatography
Extraction of yeast metabolites was performed by the rapid filtration and ethanol boiling method as
described (Loret et al., 2007) and metabolite separation was performed on an ICS3000 chromatog-
raphy station (Thermofisher) using a carbopac PA1 column (250  2 mm; Thermofisher) with the 50
to 800 mM sodium acetate gradient in NaOH 50 mM described in Ceballos-Picot et al. (2015). For
NaMN and NaAD+ determination, an improved acetate gradient was used by starting with 85 mM
acetate for the first 10 min followed by a linear gradient to reach 100 mM acetate in 20 min. The
rest of the gradient was then identical to that described in Ceballos-Picot et al. (2015). Peaks were
identified by their retention time as well as co-injection with standards and/or their UV spectrum sig-
nature (Ultimate-3000 diode array detector, Thermofisher). Peak area quantifications were done at
the following wavelengths: 240 nm for fumarate, 260 nm for ADP, AMP, ATP, GDP, GTP, guanosine,
hypoxanthine, inosine, NaAD+, NAD+ Phenylalanine, UDP, UDP-NAG, uracil and UTP; 269 nm for
adenine, NaMN, ZMP and SZMP; 272 nm for CDM, CMP, CTP and cytidine; 280 nm for Thiamine
pyrophosphate and tryptophan; 295 nm for tyrosine; 340 nm for NADH and thiamine; 360 nm for
L-kynurenine and 3-hydroxy-athranilate and 390 nm for 3-hydroxy-L-kynurenine. For each strain and
growth condition, metabolic extractions were performed on independent cell cultures (biological
replicates) and sample normalization was done on the basis of cell number and median cell volume
(using a Multisizer 4 (Beckman Coulter)). Number of biological replicates is indicated as N in the fig-
ure legends. Statistics were given as p-values determined by a Welch’s unpaired t-test assuming a
bilateral distribution and unequal variances. Welch’s t-test is more robust than Student’s t-test and
maintains type I error (rejection of the true null hypothesis) rates close to nominal for unequal varian-
ces. AXP content corresponds to the sum of ATP +ADP + AMP contents. Adenylate energy charge
(AEC), was defined as AEC = (ATP + ½ ADP)/AXP) (Atkinson and Walton, 1967). AXP and AEC
were calculated with each nucleotide content given in nmol/sample (inferred from standard curves
using ATP, ADP and AMP pure compounds).
Northern blots
The transcript levels of ADE17, BNA4, BNA6, PHO84 and ACT1 were determined by northern blot
analysis as described (Pinson et al., 2004). The BNA4 and BNA6 radiolabeled probe were obtained
by PCR on yeast genomic DNA as template using oligonucleotides couples 50-ATGTCTGAATCAG
TGGCCA-30/50-CACGTGACTTGGAAGTTATC-30 and 50-GCCTGTTTATGAACACTTATTG-30/50-CAA
TGAGCCAGTTTCAATGAG-30, respectively. The ADE17, PHO84 and ACT1 probes were already
described (Denis et al., 1998; Pinson et al., 2004). Radioactive quantification was done using a
phosphorimager (455SI; Molecular Dynamics).
Western blots
Yeast total protein extracts were obtained and separated by SDS-PAGE as described in
Escusa et al. (2006). After electro-transfer on PVDF membrane, protein were detected by western
blotting using anti-GFP (1/500; Roche #11814460001), anti-Ade13 (1/300,000; Escusa et al., 2006)
and anti-Pgk1 (1/50,000; Life technologies #459250)
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